NSCI is pleased to announce our successful IND application to the FDA that will enable clinical testing of a novel stem cell therapy for patients with age-related macular degeneration (AMD). In AMD, the retinal pigment epithelial cells (RPE) at the back of the eye degenerate, causing loss of …
NSCI Scientists Inspiring Girls in Science!
Women scientists from the NSCI - Dr. Liz Fisher, Dr. Xiuli Zhao, and Christy Allen recently took part in the Flying Cloud Institute's, Young Women In Science, STEM Summer Practicum Program. This program is aimed at inspiring young women to pursue careers in STEM through innovative collaborations …
Alima Ahmed, Student Volunteer at NSCI Wins Prestigious Award
We would like to congratulate Alima Ahmed for winning the Biomedical Sciences Excellence Award. This prestigious award recognizes the outstanding achievement of high school students in biomedical sciences research. While Alima is a student volunteer in the Boles Lab at the Neural Stem Cell …
Regenerative Eye Research- More Than Meets the Eye
Breakthroughs in Regenerative Eye Research Closer Than You Think RENSSELAER N.Y., June 08, 2018 – As the field of regenerative medicine has progressed to deliver breakthroughs throughout medicine; leading discoveries have been made in ophthalmology. A recent article published in Cell Stem Cell …
Addressing unregulated stem cell treatment centers
In recent years hundreds of unregulated stem cell treatment centers have cropped up across the U.S. These clinics claim to offer treatments for a wide variety of diseases and ailments by using patients’ own stem cells. These centers often use high-pressure sales tactics to prey on individuals and …